Autologous, Adipose derived Mesenchymal Stem Cells

BIOLOGICAL2 trials

Sponsors

Mohamad Bydon, Mayo Clinic

Conditions

ParalysisSpinal Cord Injuries

Phase 1

Adipose Stem Cells for Traumatic Spinal Cord Injury

CompletedNCT03308565

Mohamad BydonParalysis, Spinal Cord Injuries

Start: 2017-12-05End: 2021-10-11Updated: 2022-08-30

Phase 2

Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

Active, not recruitingNCT04520373

Mayo ClinicParalysis, Spinal Cord Injuries

Start: 2020-06-25End: 2026-07-31Target: 40Updated: 2025-10-14

Related Papers

Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.

2024-04-0152 citations

The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury.

2021-10-2212 citations

CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.

2019-11-2764 citations